This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...
Also in attendance is Sight Sciences, Inc. Chief Operating Officer, Alison Bauerlein. Earlier today, Sight Sciences, Inc. released its financial results for the fourth quarter ended December 31, 2025, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果